APLS Apellis Pharmaceuticals Inc

USD 47.46 0.00 0
Icon

Apellis Pharmaceuticals Inc (APLS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 47.46

0.00 (0.00)%

USD 5.76B

1.11M

USD 78.57(+65.55%)

USD 48.33 (+1.83%)

Icon

APLS

Apellis Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 47.46
0.00 0
Take a Tour

Apellis Pharmaceuticals Inc (APLS) Stock Forecast

Show ratings and price targets of :
USD 78.57
(+65.55%)

Based on the Apellis Pharmaceuticals Inc stock forecast from 12 analysts, the average analyst target price for Apellis Pharmaceuticals Inc is USD 78.57 over the next 12 months. Apellis Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Apellis Pharmaceuticals Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Apellis Pharmaceuticals Inc’s stock price was USD 47.46. Apellis Pharmaceuticals Inc’s stock price has changed by -4.81% over the past week, -15.33% over the past month and -49.07% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...